Monday, March 14, 2022 5:23:08 PM
$90M for 2022 with intentions to add an additional $80 million to that forecast through the other arms of business seems like good news to me considering the MCAP is sitting at $68M at the moment.
I believe this figure is fluid as most of these deals are constantly being negotiated throughout many subsidiaries. So I wouldn't expect a response until deals are done. Keep in mind it could be more. Last years guidance was beat so they have a history of overdelivering on revenue forecast.
Unfortunately we are in one of the ugliest pullbacks the market has seen in quite some time but this magnifies the significance of finding solid undervalued companies. Even large caps right now are moving like penny stocks. AAPL is down 16% YTD....ever heard of them? TSLA down 28%. FB down 44%. AARK down 60% yearly. I could go on and on. Almost every stock is down some as much as 80%. Blue chip, Dow, Nasdaq, MidCap, large cap, Crypto, good news, earnings beat.....it doesn't matter. Any company with a high multiple is getting gut checked right now.
With all things considered we are holding up pretty good here.
IQST has been doing work, making deals, winning awards and paying off debt in a responsible matter.
I believe the shorts know this thing can rip anytime now and are not willing to risk it. Clearly the bulls know it as well and are holding their shares with both hooves.
Recent IQST News
- Form 8-K - Current report • Edgar (US Regulatory) • 03/05/2024 09:56:04 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 03/04/2024 10:19:27 PM
- Form S-1 - General form for registration of securities under the Securities Act of 1933 • Edgar (US Regulatory) • 02/13/2024 04:40:15 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 02/13/2024 03:47:57 PM
- Form 8-K/A - Current report: [Amend] • Edgar (US Regulatory) • 02/08/2024 02:18:44 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 02/06/2024 08:37:10 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 02/05/2024 05:28:56 PM
- Form 8-K/A - Current report: [Amend] • Edgar (US Regulatory) • 01/30/2024 09:58:55 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 01/29/2024 09:24:49 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 01/25/2024 10:26:52 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 01/25/2024 10:22:44 PM
- IQST - iQSTEL and QXTEL Announce a Deal To Become Quarter Billion Revenue Corporation • InvestorsHub NewsWire • 01/22/2024 02:56:12 PM
- Will Acquisition News Send Shares of this Telecom Firm Higher? • AllPennyStocks.com • 01/22/2024 02:00:00 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 01/02/2024 05:11:18 PM
- Form DEF 14A - Other definitive proxy statements • Edgar (US Regulatory) • 12/28/2023 08:29:17 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 11/14/2023 05:12:58 PM
- Company Preparing for Uplisting Announces YTD Results • AllPennyStocks.com • 10/19/2023 03:50:00 PM
- Form EFFECT - Notice of Effectiveness • Edgar (US Regulatory) • 09/28/2023 04:15:24 AM
- Form 8-K - Current report • Edgar (US Regulatory) • 09/13/2023 08:04:54 PM
- IQST - iQSTEL Signs $10M Term Sheet with LDA Capital to Back Nasdaq Uplist Plan • InvestorsHub NewsWire • 09/13/2023 02:03:11 PM
- IQST - iQSTEL Announces $83 Million YTD Revenue Besting Forecasted Rate • InvestorsHub NewsWire • 09/07/2023 01:22:35 PM
- IQST - iQSTEL Engages First Prospects For AI-Enhanced Metaverse App V1.2 • InvestorsHub NewsWire • 08/29/2023 04:57:24 PM
- Form S-1/A - General form for registration of securities under the Securities Act of 1933: [Amend] • Edgar (US Regulatory) • 08/25/2023 08:54:39 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 08/14/2023 05:40:46 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 07/19/2023 08:46:36 PM
FEATURED Cannabix Technologies Launches New Compact Breath Logix Workplace Series and Prepares for Delivery to South Africa • May 7, 2024 8:51 AM
Moon Equity Holdings, Corp. Announces Acquisition of Wikolo, Inc. • MONI • May 7, 2024 9:48 AM
NanoViricides Reports that the Phase I NV-387 Clinical Trial is Completed Successfully and Data Lock is Expected Soon • NNVC • May 2, 2024 10:07 AM
ILUS Files Form 10-K and Provides Shareholder Update • ILUS • May 2, 2024 8:52 AM
Avant Technologies Names New CEO Following Acquisition of Healthcare Technology and Data Integration Firm • AVAI • May 2, 2024 8:00 AM
Bantec Engaged in a Letter of Intent to Acquire a Small New Jersey Based Manufacturing Company • BANT • May 1, 2024 10:00 AM